Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Technology Industry News Goldman Sachs Alternatives leads $100m investment in Neural Concept to accelerate AI-driven engineering design Find out how Goldman Sachs Alternatives’ $100 million investment is accelerating Neural Concept’s AI-driven engineering design platform and reshaping industrial innovation. bySoujanya RaviDecember 18, 2025